Gilead Sciences, Inc. GILD announced that the FDA accepted Kite’s Biologics License Application (BLA) and granted Priority Review designation to investigational chimeric antigen receptor (CAR) T cell ...

Priority review for investigational CTL019 (tisagenlecleucel-T), a novel therapy that is manufactured for each individual patient using their own T cells Novartis made an early commitment to the ...

Bristol Myers Squibb and bluebird bio submitted a second Biologics License Application (BLA) to the FDA for idecabtagene vicleucel (ide-cel), the companies’ investigational B-cell maturation ...

Bla Bla Car, which has 20 million members worldwide, connects car owners who are planning to drive from one city to another and passengers who want to make the same journey at the same time. The Only ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Biopharma company Kite, a subsidiary of ...

A collection of the most-viewed Moneycontrol videos. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting ...